2000
DOI: 10.3748/wjg.v6.i1.69
|View full text |Cite
|
Sign up to set email alerts
|

Expression of gap junction genes connexin 32, connexin 43 and their proteins in hepatocellular carcinoma and normal liver tissues

Abstract: AIM To investigate the significance and mechanism of cx-32 mRNA, cx-43 mRNA and their proteins in hepatocarcinogenesis. METHODS Sixty-one cases of HCC and 14 cases of normal liver tissues were detected by immunohistochemical and in situ hybridization (ISH) methods. RESULTS In HCC grades I, II, III and normal liver tissues, the positive rates of Cx32 protein were 55.6%, 42.1%, 18.2% and 92.9%, respectively. The detection rates of Cx43 protein were 44%, 26.3%, 12.1% and 78.6%, respectively. There was significant… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
3

Year Published

2006
2006
2012
2012

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(13 citation statements)
references
References 2 publications
0
10
0
3
Order By: Relevance
“…In addition, in cultures of primary hepatocytes, which are inherently prone to alterations in the differentiation status and thus can serve as an experimental model to study this condition, inhibitors of histone deacetylases, constituting another critical determinant of the epigenome, have been demonstrated to affect connexin expression and GJIC in favour of the differentiated status (Vinken et al, 2006c(Vinken et al, , 2007. Another hallmark of tumour cells includes aberrant connexin localisation (Leithe et al, 2006;Ma et al, 2000Ma et al, , 2002Ma et al, , 2003Mesnil et al, 2005). Thus, Cx32 typically accumulates in the cytoplasm of cancerous human hepatocytes, both in vitro and in vivo (Kawasaki et al, 2011;Li et al, 2007).…”
Section: Connexins and Alterations In The Liver Differentiation Statusmentioning
confidence: 99%
“…In addition, in cultures of primary hepatocytes, which are inherently prone to alterations in the differentiation status and thus can serve as an experimental model to study this condition, inhibitors of histone deacetylases, constituting another critical determinant of the epigenome, have been demonstrated to affect connexin expression and GJIC in favour of the differentiated status (Vinken et al, 2006c(Vinken et al, , 2007. Another hallmark of tumour cells includes aberrant connexin localisation (Leithe et al, 2006;Ma et al, 2000Ma et al, , 2002Ma et al, , 2003Mesnil et al, 2005). Thus, Cx32 typically accumulates in the cytoplasm of cancerous human hepatocytes, both in vitro and in vivo (Kawasaki et al, 2011;Li et al, 2007).…”
Section: Connexins and Alterations In The Liver Differentiation Statusmentioning
confidence: 99%
“…Disruption of connexins has been frequently reported in malignant tumor cells such as hepatocellular carcinoma (5) and breast carcinoma (6), and in carcinogenesis of the cervix (7) and endometrium (8). Saitoh et al demonstrated changes in the expression of Cx26 and 43 in hamster tongue epithelium during wound healing and carcinogenesis (9).…”
Section: Introductionmentioning
confidence: 99%
“…Diversos estudos relacionados à carcinogênese também demonstraram redução das conexinas, indicando-as como genes supressores de tumores e de grande relevância nos eventos de transformação celular (TEMME et al, 1997;OMORI et al, 2001;MA et al, 2000MA et al, , 2002EVERT et al, 2002).…”
Section: Conexinas Nas Doenças Hepáticas Crônicasunclassified
“…No entanto, esta correlação nem sempre se mostra fidedigna em todos os tipos celulares (KARDAMI et al, 2007) ou nos diferentes processos patológicos (DAGLI; HERNANDEZ-BLAZQUEZ, 2007). Alguns estudos realizados em animais com deficiência de Cx32 demonstraram maior susceptibilidade destes animais ao desenvolvimento de tumores hepáticos (TEMME et al, 1997;MA et al, 2000MA et al, , 2002OMORI et al, 2001;EVERT et al, 2002). No entanto, estes mesmos animais submetidos ao modelo da hepatectomia parcial apresentaram menor proliferação celular dos hepatócitos (TEMME et al, 2000).…”
Section: Timp-1 Mm00441818_m1unclassified